Type 3 Diabetes: Metabolic Causes of Alzheimer’s Disease
Here is an in-depth article on Alzheimer’s Disease, which is sometimes called Type 3 Diabetes.
“As the population of the industrialized world ages, illnesses associated with aging consume a larger portion of our healthcare budgets and impose increasing burdens on the quality of life of patients and their caregivers. Estimates suggest that in the U.S., Alzheimer’s disease (AD) affects 12 percent of people over age 65 and nearly 50 percent of those over 85, with predictions for this to include 16 million people by 2050.1 National healthcare costs associated with AD are expected to surpass one trillion dollars by mid-century.1
Considering the fact that AD has no known cure and current therapies are largely ineffective, identifying the triggering mechanisms and exacerbating factors behind AD is of paramount importance, as prevention and early detection would serve to decrease—or at the very least delay—the physical, emotional and financial hardships this illness creates. Prevention is also critical because AD symptoms often do not appear until loss of functional neurons is so widespread that irreversible damage has already occurred.”